"
Team:Groningen/Template/MODULE/project/MBD/results
From 2014.igem.org
(Difference between revisions)
Ottoschepers (Talk | contribs) |
Ottoschepers (Talk | contribs) |
||
| Line 22: | Line 22: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
| - | <td>1</td><td>3 h</td><td>something</td><td>something</td> | + | <td>1</td><td>3 h</td><td>something</td><td>something</td><td>something</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Revision as of 23:27, 17 October 2014
Conclusion
| Design | Tnisin | TAiiA | TDspB | Rating |
|---|---|---|---|---|
| 1 | 3 h | something | something | something |
| 2 | ? | After being applied to the wound. Amount of time for reaching the inhibitory concentrations of nisin, DspB and AiiA to pass the bottom membrane and into the wound. | ||
| 3 | tbd | In what quantity does S. aureus need to be detected? | ||
| 4 | tbd | In what quantity does P. aeruginosa need to be detected? | ||
| 5 | 2-16 ng/µL | This concentration can be used for both MRSA and VRE. Source: Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity ……. Brumfitt, Salton, Hamilton-Miller. | ||
| 6 | tbd | How much is needed to inhibit growth of PA/SA? |
Our results in textformat
Figure 1:
Proin finibus nisi ut enim fermentum finibus ut egestas dolor. Vestibulum cursus eu dolor vehicula faucibus. Sed sed pharetra arcu. Pellentesque venenatis viverra justo a aliquet. Pellentesque venenatis viverra justo a aliquet. Praesent sit amet metus in ligula porttitor maximus. Pellentesque varius ligula lacus.
